🔗 Permalink

Inventor profile of:

Bernd Liepold

City:

Dossenheim

Country:

Germany

Published Applications:

Last publication date:

2024-06-20

Top Assignees for applications by Bernd Liepold

The entities that hold a legal rights for patent applications filed by inventor Liepold Bernd:

ABBVIE INC. 8 North Chicago, IL United States
Abbott Laboratories 7 Abbott Park, IL United States
Abbott GmbH & Co. KG 5 Wiesbaden, Germany
AbbVie Deutschland GmbH & Co. KG 4 Wiesbaden, Germany
AbbVie Deutschland GmbH & Co. KG 2 Wiesbaden, Germany
BDS Pharma GmbH 1 Graz, Austria
ABBOTT GMBH & CO. KG 1 Wiesbaden-Delkenheim, Germany
Peter Holig 1 Wachtersbach, Germany
Jorg Breitenbach 1 Mannheim, Germany
AbbVie Inc. 1 Waukegan, IL United States

Recent patent applications by Liepold Bernd

Bernd Liepold from Dossenheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-06-20

US20240197757A1

Human necessities

PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR

#2 | 2022-04-14

US20220110951A1

Human necessities

PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR

#3 | 2021-04-01

US20210093649A1

Human necessities

PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR

#4 | 2019-09-05

US20190269704A1

Human necessities

PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR

#5 | 2017-12-28

US20170368066A1

Human necessities

Solid antiviral dosage forms

#6 | 2017-07-06

US20170189426A1

Human necessities

PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL-2 FAMILY INHIBITOR

#7 | 2016-07-14

US20160199374A1

Human necessities

Solid antiviral dosage forms

#8 | 2015-09-17

US20150258093A1

Human necessities

Solid antiviral dosage forms

#9 | 2015-05-21

US20150141351A1

Human necessities

Solid Pharmaceutical Compositions

#10 | 2014-10-02

US20140296336A1

Human necessities

Solid retard formulations based on solid dispersions

#11 | 2014-07-17

US20140200278A1

Human necessities

Pharmaceutical dosage form comprising polymeric carrier composition

#12 | 2014-06-26

US20140179721A1

Human necessities

SOLID PHARMACEUTICAL DOSAGE FORM

#13 | 2014-06-19

US20140171481A1

Human necessities

SOLID COMPOSITIONS

#14 | 2013-05-16

US20130118238A1

Physics

Test solvent for evaluating the compatibility of biologically active substances and graft copolymers

#15 | 2013-03-21

US20130072508A1

Human necessities

Solid pharmaceutical dosage form

#16 | 2013-01-03

US20130004578A1

Human necessities

Solid Pharmaceutical Dosage Formulation

#17 | 2012-10-11

US20120258909A1

Human necessities

Solid compositions

#18 | 2012-10-04

US20120252851A1

Human necessities

Delivery system for sustained release of a calcium-channel blocking agent

#19 | 2012-08-09

US20120202858A1

Human necessities

Solid pharmaceutical dosage form

#20 | 2012-01-26

US20120022089A1

Human necessities

Solid pharmaceutical dosage form

#21 | 2011-12-22

US20110312973A1

Human necessities

SOLID COMPOSITIONS

#22 | 2011-07-28

US20110182891A1

Human necessities

PHARMACEUTICAL DOSAGE FORM COMPRISING POLYMERIC CARRIER COMPOSITION

#23 | 2011-01-20

US20110015216A1

Human necessities

Solid pharmaceutical dosage form

#24 | 2011-01-13

US20110008430A1

Human necessities

Solid pharmaceutical dosage form

#25 | 2010-12-09

US20100310648A1

Human necessities

Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor

#26 | 2010-11-25

US20100297194A1

Human necessities

FORMULATION FOR ORAL ADMINISTRATION OF APOPTOSIS PROMOTER

#27 | 2010-06-10

US20100143459A1

Human necessities

PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF TYROSINE KINASE INHIBITOR

#28 | 2009-01-08

US20090012184A1

Human necessities

Production of dosage forms comprising a solid dispersion of a microcrystalline agent

#29 | 2008-07-31

US20080181948A1

Human necessities

SOLID PHARMACEUTICAL DOSAGE FORMULATIONS

#30 | 2005-04-21

US20050084529A1

Human necessities

Solid pharmaceutical dosage form

InventorID:

10872 ⎘